Shanu Modi MD

Shanu Modi, MD, is an Associate Professor of Medicine in the Department of Medicine at Weill Cornell Medical College in New York, New York. She is also an Associate Member of the Breast Medicine Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, New York. Dr. Modi received her medical degree from the University of Alberta in Edmonton, Canada where she also completed a residency in internal medicine. She followed this with subspecialty training in medical oncology at the Cross Cancer Institute and subsequently completed a 4-year fellowship in breast cancer research at MSKCC. She has been a full-time faculty member of the Breast Medicine Service at MSKCC since 2005.

Dr. Modi has been chair and member of the Scientific Program Committee for HER2 Positive Breast Cancer from 2013 to 2016 and member of the Grants Selection Committee for the American Society of Clinical Oncology (ASCO) from 2013 to 2015. She received the Conquer Cancer Foundation Advanced Clinical Research Award in 2009 for her work in Heat Shock Protein Inhibition. Dr. Modi was awarded and held the Patricia and James Cayne Chair for Junior Faculty at MSKCC from 2009 to 2012.

She has had a clinical research career in the development of HER2- targeted therapies and is currently the Section Head for HER2 Positive Breast Cancer for the Breast Medicine Service at MSKCC. Dr. Modi is also a member of the Expert Committee to establish Guidelines for Patients with Advanced HER2+ Breast Cancer, where she serves on the Breast Cancer Consensus Panel. She is also a member of the Scientific Committee for the European Society of Medical Oncology (ESMO) as part of the metastatic breast cancer track responsible for the abstract selection.

She is an ad hoc reviewer for Journal of Clinical Oncology, Clinical Breast Cancer, Breast Cancer Research and Treatment, and Journal of Surgical Oncology. She has authored or co-authored more than 50 peer-reviewed articles as well as books, book chapters, and reviews.

Dr. Modi holds memberships in ASCO, ESMO, the American Association for Cancer Research, ALLIANCE for Clinical Trials in Oncology, and the Translational Breast Cancer Consortium. She has been an invited speaker for national and international congresses, meetings, and symposiums.